Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "child"

521 News Found

Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions
Drug Approval | June 29, 2022

Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions

Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2


COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
Healthcare | June 16, 2022

COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute

Many kids who have heart transplants live a normal, healthy life once they recover from surgery.


Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa
Public Health | June 15, 2022

Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for HIV in South Africa

This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.


Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions
Biotech | May 21, 2022

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions

Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU


Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City
Public Health | May 08, 2022

Thalassemia children require comprehensive treatment approach: Dr Sunil Bhat, Narayana Health City

There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous


Moderna files for authorization of its Covid-19 vaccine in young children six months to six years
Biotech | April 29, 2022

Moderna files for authorization of its Covid-19 vaccine in young children six months to six years

Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children


USFDA approves first Covid-19 treatment for young children
Drug Approval | April 26, 2022

USFDA approves first Covid-19 treatment for young children

This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age


DCGI grants Covaxin Emergency Use Approval for children 6-12 years
Drug Approval | April 26, 2022

DCGI grants Covaxin Emergency Use Approval for children 6-12 years

Covaxin was earlier approved for children 12-18 years of age


Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)
News | March 18, 2022

Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)

The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years


Corbevax to be administered to children between 12-14 years
News | March 14, 2022

Corbevax to be administered to children between 12-14 years

Govt announces vaccination programme for kids and those above 60 years of age